Skip to main content
. Author manuscript; available in PMC: 2015 Dec 16.
Published in final edited form as: Cancer Immunol Res. 2015 Mar 13;3(5):567–574. doi: 10.1158/2326-6066.CIR-14-0188

Table 3.

Results of the univariate Cox regression model for OSa (n = 42)

n HR (95% CI) P value
Patient characteristics
 Gender
  Male 31 1.0 0.44
  Female 9 0.7 (0.3–1.7)
 Race
  White 30 1.0 0.77
  Black 6 0.9 (0.3–2.3)
 Race
  White 30 1.0 0.98
  Other 10 1.0 (0.5–2.2)
 Age 40 1.0 (0.9–1.0) 0.28
Clinical measures
 Primary tumor site
  Non-OP 24 1.0 0.74
  OP 16 0.9 (0.4–1.8)
 Polymorphism
  FF 14 1.0 0.82
  FV or VV 21 0.9 (0.4–1.9)
 Surgery (in addition to treatment)
  No surgery 14 1.0 0.86
  Surgery 25 0.9 (0.5–1.9)
 P16 staining
  Negative 7 1.0 0.09
  Positive 6 0.3 (0.1–1.2)
 ADCC response
  No Response 17 1.0 0.85
  Response 8 1.1 (0.4–2.9)

Abbreviation: OP, oropharynx.

a

OS is defined from the date of start of treatment till the date of death or censored at the date last known alive.